LT2144924T - Sulieto baltymo vakcina - Google Patents

Sulieto baltymo vakcina

Info

Publication number
LT2144924T
LT2144924T LTEP08724181.6T LT08724181T LT2144924T LT 2144924 T LT2144924 T LT 2144924T LT 08724181 T LT08724181 T LT 08724181T LT 2144924 T LT2144924 T LT 2144924T
Authority
LT
Lithuania
Prior art keywords
fusion protein
protein vaccine
vaccine
fusion
protein
Prior art date
Application number
LTEP08724181.6T
Other languages
English (en)
Inventor
Gunnar Lindahl
Original Assignee
Minervax Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minervax Aps filed Critical Minervax Aps
Publication of LT2144924T publication Critical patent/LT2144924T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
LTEP08724181.6T 2007-04-16 2008-04-14 Sulieto baltymo vakcina LT2144924T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700919 2007-04-16
US94047307P 2007-05-29 2007-05-29
PCT/SE2008/000270 WO2008127179A1 (en) 2007-04-16 2008-04-14 Fusion protein vaccine

Publications (1)

Publication Number Publication Date
LT2144924T true LT2144924T (lt) 2016-10-10

Family

ID=39864173

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP08724181.6T LT2144924T (lt) 2007-04-16 2008-04-14 Sulieto baltymo vakcina

Country Status (15)

Country Link
US (1) US8313748B2 (lt)
EP (1) EP2144924B1 (lt)
CN (1) CN101855238B (lt)
CA (1) CA2684494C (lt)
CY (1) CY1117896T1 (lt)
DK (1) DK2144924T3 (lt)
ES (1) ES2586418T3 (lt)
HR (1) HRP20160995T1 (lt)
HU (1) HUE028253T2 (lt)
LT (1) LT2144924T (lt)
PL (1) PL2144924T3 (lt)
PT (1) PT2144924T (lt)
RU (1) RU2487890C2 (lt)
SI (1) SI2144924T1 (lt)
WO (1) WO2008127179A1 (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014018904A1 (en) * 2012-07-26 2014-01-30 Genocea Biosciences, Inc. Fused antigen vaccines and compositions against streptococcus pneumoniae
CN104582718B (zh) 2012-10-03 2017-10-24 诺华股份有限公司 免疫原性组合物
CN103694323B (zh) * 2013-12-09 2017-01-18 成都欧林生物科技股份有限公司 金黄色葡萄球菌MntC重组蛋白及其制备方法和应用
CN108135992A (zh) * 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
WO2017114655A1 (en) * 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
WO2021099982A1 (en) 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4165065A2 (en) 2020-06-12 2023-04-19 GlaxoSmithKline Biologicals S.A. Gbs ferritin nanoparticles
EP4165064A2 (en) 2020-06-12 2023-04-19 GlaxoSmithKline Biologicals S.A. Dock tag system
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
CN116478953B (zh) * 2023-06-14 2023-09-12 四川大学华西医院 鲍曼不动杆菌DlaT重组蛋白、制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225579A (en) * 1979-02-27 1980-09-30 Israel Kleinberg Means and method for improving defenses against caries
US4496538A (en) 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
WO1994001031A1 (fr) 1992-07-02 1994-01-20 Paul Charvet Appareil de cuisson dans l'huile a chauffage au gaz
CA2123579C (en) * 1992-09-16 2005-05-10 James B. Dale Recombinant multivalent m protein vaccine
IL107458A0 (en) 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
ATE240351T1 (de) 1993-03-19 2003-05-15 Gunnar Lindahl Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6426074B1 (en) 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
PT1601689E (pt) * 2003-03-13 2008-01-04 Glaxosmithkline Biolog Sa Processo de purificação para citolisina bacteriana
EP1663303B1 (en) 2003-09-15 2011-05-04 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for streptococcus agalactiae

Also Published As

Publication number Publication date
RU2009142976A (ru) 2011-05-27
CA2684494A1 (en) 2008-10-23
HRP20160995T1 (hr) 2016-10-21
WO2008127179A1 (en) 2008-10-23
EP2144924A1 (en) 2010-01-20
US8313748B2 (en) 2012-11-20
CN101855238B (zh) 2014-09-17
HUE028253T2 (en) 2017-02-28
CA2684494C (en) 2016-07-05
EP2144924B1 (en) 2016-05-11
EP2144924A4 (en) 2010-08-25
SI2144924T1 (sl) 2016-12-30
CN101855238A (zh) 2010-10-06
RU2487890C2 (ru) 2013-07-20
US20100062015A1 (en) 2010-03-11
WO2008127179A8 (en) 2009-07-23
PL2144924T3 (pl) 2017-06-30
ES2586418T3 (es) 2016-10-14
DK2144924T3 (en) 2016-08-22
CY1117896T1 (el) 2017-05-17
PT2144924T (pt) 2016-08-17

Similar Documents

Publication Publication Date Title
HK1219490A1 (zh) 免疫球蛋白融合蛋白
IL196889A0 (en) Albumin-insulin fusion proteins
EP2144924A4 (en) FUSION PROTEIN VACCINE
IL204839A0 (en) Albumin fusion proteins
IL219048A (en) Peptide compounds derived from urcl10
PT3118220T (pt) Proteína
EP2173377A4 (en) ANTIBODY-ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS
ZA200906699B (en) Insecticidal proteins
HK1138853A1 (en) Vaccine
IL205716A0 (en) Formulations for taci-immunoglobulin fusion proteins
GB0700135D0 (en) Vaccine
ZA201001029B (en) Vaccines
GB0725201D0 (en) Peptide fusion proteins
GB0719231D0 (en) Protein
GB2465684B (en) Biocidal fusion peptides
GB0700759D0 (en) Novel fusion protein
GB0720563D0 (en) Protein
GB0713169D0 (en) Fusion proteins
GB0709707D0 (en) Novel fusion protein
GB0719236D0 (en) Protein
GB0713302D0 (en) Protein
GB0716224D0 (en) Peptides for vaccine
GB0715413D0 (en) Fusion skyer
GB0715933D0 (en) Fusion snicker
IL206541A0 (en) Novel protein